Brown Gibbons Lang & Company (BGL), an independent investment bank and financial advisory firm, has entered into an agreement to become a long-term Alliance Partner of the annual DxPx Conference, which is hosted parallel to MEDICA in Duesseldorf, Germany. The DxPx Conference is an event for emerging growth companies, global industry participants, and investors in diagnostics and research tools; it is designed to facilitate licensing, financing, co-development and M&A opportunities.
“BGL has decades of experience advising companies across the diagnostics and research tools industry regarding capital formation, technology strategy, corporate ventures, and M&A strategy,” said Christoph Brandenberger, Managing Director. “We maintain active relationships with global industry participants and capital providers, and are always looking to expand our network and our reach in order to provide the best opportunities for our clients. The DxPx Conference is an exciting new forum in our industry, and therefore seemed like a natural fit for partnership.”
The DxPx Conference is sponsored by a number of prestigious companies, such as: Aescuvest, Sonic Healthcare’s Bioscientia, Hightech Gründerfund, MEDICA, Medicover, MyBioGate, Pillar Biosciences, Roche Diagnostics, SHS, and McDermott Will & Emery.
“Our partnership with Brown Gibbons Lang & Company reflects BGL’s status as a top investment banking and financial advisory firm in the life sciences industry,” said DxPx Founder Dr. Mirko Stange. “Their existing expertise and rapid growth within the diagnostics and research tools sector makes them the perfect partner with whom to plan and host this event.”
This year’s DxPx Conference takes place on November 18, 2019 in Duesseldorf, Germany, at the Maritim Airport Hotel. The conference, because it is held in conjunction with the first day of the MEDICA conference, offers participants from Asia and North America, in addition to European countries, the chance to attend complimentary events during their visit to Duesseldorf. Over 350 participants from more than 15 countries are expected to participate this year.
In addition to prescheduled, one-on-one meetings, the Conference will feature panel discussions on topics such as reimbursement, cross-border M&A, and point-of-care diagnostics. The event will also facilitate startup pitches; interested entrepreneurs and companies should apply for the opportunity to present their ideas and products live on stage to an international audience. If selected, they can attend the conference for free, and compete for the chance to win DxPx awards, such as a fully-paid investor roadshow in China. Application is free of charge; applicants need only submit a one-page business plan via www.dxpx-conference.com. The Conference’s sponsors and select industry experts will act as the awards jury.